In a case-control study, Imagawa et al. studied IgM, IgG, and IgA antibodies against EV, using ELISA, in 19 patients with recent-onset fulminant T1DM, 18 patients with recent-onset typical T1DM, and 19 healthy subjects (Table 2). This evidence concerns the gene CD40LG and type 1 diabetes mellitus.